Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
| ▸ | CDK4 | P11802 | 3/20 | 0.35 |
| ▸ | CCND3 | P30281 | 3/20 | 0.35 |
| ▸ | CDK6 | Q00534 | 3/20 | 0.35 |
| ▸ | BTK | Q06187 | 4/20 | 0.33 |
| ▸ | MAPK3 | P27361 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.33 |
| ▸ | INSR | P06213 | 2/20 | 0.32 |
| ▸ | IGF1R | P08069 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.32 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.32 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
| ▸ | CDK9 | P50750 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22650519 | 0.91 | EGFR (0.36) | EGFRCDK4CCND3CDK6MAPK3 | |
| SCHEMBL22650707 | 0.90 | JAK2 (0.39) | CDK4BTKROCK2CDK1CDK9 | |
| SCHEMBL22650450 | 0.88 | CDK4 (0.41) | CDK4CCND3CDK6CDK1CCNA2 | |
| SCHEMBL22650940 | 0.83 | BTK (0.38) | CDK4BTKCDK1CDK9 | |
| SCHEMBL22650597 | 0.82 | EGFR (0.37) | EGFRCDK4MAPK3MAPK1CCNA2 | |
| SCHEMBL22650922 | 0.82 | F10 (0.38) | EGFRJAK2JAK3 | |
| SCHEMBL22650524 | 0.82 | CDK6 (0.38) | EGFRCDK4CCND3CDK6MAPK3 | |
| SCHEMBL22650523 | 0.82 | EGFR (0.42) | EGFRIGF1RJAK2 | |
| SCHEMBL22650433 | 0.81 | EGFR (0.36) | EGFRCDK4CCND3CDK6MAPK3 | |
| SCHEMBL22650709 | 0.81 | JAK2 (0.39) | CDK4CDK1CDK9JAK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020224568-A1 | CDK INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2020-11-12 | — | — | WO | disclosed |